A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Paricalcitol
Clenbuterol
The risk or severity of hypertension can be increased when Clenbuterol is combined with Aminophenazone.
Paricalcitol
Procaterol
The risk or severity of hypertension can be increased when Procaterol is combined with Aminophenazone.
Paricalcitol
Mephentermine
The risk or severity of hypertension can be increased when Mephentermine is combined with Aminophenazone.
Paricalcitol
Ephedra sinica root
The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Aminophenazone.
Paricalcitol
Pirbuterol
The risk or severity of hypertension can be increased when Pirbuterol is combined with Aminophenazone.
Paricalcitol
Fenoterol
The risk or severity of hypertension can be increased when Fenoterol is combined with Aminophenazone.
Paricalcitol
Isocarboxazid
The risk or severity of hypertension can be increased when Isocarboxazid is combined with Aminophenazone.
Paricalcitol
Desflurane
The risk or severity of hypertension can be increased when Desflurane is combined with Aminophenazone.
Paricalcitol
Arbutamine
The risk or severity of hypertension can be increased when Arbutamine is combined with Aminophenazone.
Paricalcitol
Isoprenaline
The risk or severity of hypertension can be increased when Isoprenaline is combined with Aminophenazone.
Paricalcitol
Naratriptan
The risk or severity of hypertension can be increased when Naratriptan is combined with Aminophenazone.
Paricalcitol
Diethylpropion
The risk or severity of hypertension can be increased when Diethylpropion is combined with Aminophenazone.
Paricalcitol
Oxymetazoline
The risk or severity of hypertension can be increased when Oxymetazoline is combined with Aminophenazone.
Paricalcitol
Teriflunomide
The serum concentration of Aminophenazone can be decreased when it is combined with Teriflunomide.
Paricalcitol
Cilostazol
The serum concentration of Cilostazol can be increased when it is combined with Aminophenazone.
Tiagabine
Satralizumab
The serum concentration of Testosterone propionate can be decreased when it is combined with Satralizumab.
Tiagabine
Abametapir
The serum concentration of Testosterone propionate can be increased when it is combined with Abametapir.
Tiagabine
Sacituzumab govitecan
The serum concentration of Sacituzumab govitecan can be decreased when it is combined with Testosterone propionate.
Tiagabine
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Testosterone propionate.
Tiagabine
Cenobamate
The serum concentration of Testosterone propionate can be decreased when it is combined with Cenobamate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3